PeptideDB

Bromperidol HCl 59453-24-6

Bromperidol HCl 59453-24-6

CAS No.: 59453-24-6

Bromperidol (R-11333) HCl has antipsychotic activity and has high affinity for central dopamine receptors D2. Bromperido
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bromperidol (R-11333) HCl has antipsychotic activity and has high affinity for central dopamine receptors D2. Bromperidol HCl and Spectinomycin can synergistically kill Mycobacteria.

Physicochemical Properties


Molecular Formula C21H24BRCLFNO2
Molecular Weight 456.78
Exact Mass 455.066
CAS # 59453-24-6
Related CAS # Bromperidol;10457-90-6
PubChem CID 164517260
Appearance White to off-white solid powder
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 6
Heavy Atom Count 27
Complexity 451
Defined Atom Stereocenter Count 0
InChi Key XAYXCUZHMISKSM-UHFFFAOYSA-N
InChi Code

InChI=1S/C21H23BrFNO2.ClH/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16;/h3-10,26H,1-2,11-15H2;1H
Chemical Name

4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one;hydrochloride
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vivo In addition to inhibiting conditioned responses and learnt intracranial self-stimulation in rats, bromoperidol hydrochloride can counteract stereotyped behaviors and agitation brought on by apomorphine or amphetamine [1]. In dogs, apomorphine-induced vomiting can be countered and the conditioned avoidance response can be inhibited by bromperidol hydrochloride [1].
References [1]. Benfield P, et al. Bromperidol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in psychoses. Drugs. 1988 Jun;35(6):670-84.
[2]. Ramón-García S, et al. Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen. Antimicrob Agents Chemother. 2011 Aug;55(8):3861-9.

Solubility Data


Solubility (In Vitro) DMSO : ≥ 100 mg/mL (~218.92 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.47 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.1892 mL 10.9462 mL 21.8924 mL
5 mM 0.4378 mL 2.1892 mL 4.3785 mL
10 mM 0.2189 mL 1.0946 mL 2.1892 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.